Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online October 15, 2020.
Article Versions
- You are currently viewing a Latest version of this article (October 15, 2020 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2020 The Journal of Rheumatology
Author Information
- David J. Margolis,
- Nandita Mitra and
- Dimitri S. Monos
- Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania; Department of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
This work was supported in part by grants from the National Institutes for Health (NIAMS) R01-AR060962 (PI: Margolis) and R01-AR070873 (MPI: Margolis/Monos). The Pediatric Eczema Elective Registry (PEER) study is funded as the Atopic Dermatitis Registry by Valeant Pharmaceuticals International (PI: Margolis). D.J. Margolis is or recently has been a consultant for Pfizer, Leo, and Sanofi with respect to studies of atopic dermatitis and serves on an advisory board for the National Eczema Association. D.S. Monos is Chair of the Scientific Advisory Board of Omixon, and owns options in and receives royalties from Omixon.
Address correspondence to Dr. D.J. Margolis, MD, PhD, 901 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104, USA. Email: margo@pennmedicine.upenn.edu.